Asia's Top 10 Cell Culture Based Rabies Vaccines Brand List

May 28, 2024

The cell culture based rabies vaccines market is rapidly growing due to their higher safety profile and efficacy compared to traditional vaccines. With increasing awareness about the importance of Rabies Prevention, demand for these vaccines is expected to rise, especially in developing countries where the disease is more prevalent. Major players in the market are investing in research and development to improve vaccine formulations and production processes, further driving market growth.

Rabipur
Changchun Zhuoyi Biological Co., Ltd
Rabifast
Verorab
Abhayrab

Rabipur

Establishment time : 1986

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a leading pharmaceutical company specializing in the production of rabies vaccines. Established in 1986, the company has grown to become a key player in the global market, providing high-quality vaccines to prevent rabies in humans. With a large presence and distribution network, Rabipur continues to innovate and improve its products to meet the growing demand for rabies prevention worldwide.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Rabifast

Establishment time : 2005

website : www.rabifast.com

Main Product : Pharmaceuticals and healthcare products

Company Profile

Rabifast is a leading pharmaceutical company dedicated to providing high-quality and affordable healthcare products to improve the lives of people around the world. With a strong focus on research and development, Rabifast strives to innovate and bring cutting-edge solutions to the market.

Verorab

Establishment time : Verorab is a rabies vaccine manufactured by Sanofi Pasteur.

website :

Main Product : Sanofi is a global pharmaceutical company with a strong presence in the vaccine market.

Company Profile

Verorab is a trusted and effective option for rabies prevention.

Abhayrab

Establishment time : Abhayrab is a pharmaceutical company founded in 1985.

website :

Main Product : Our company has a medium-sized workforce dedicated to delivering high-quality healthcare solutions.

Company Profile

Visit our website at www.abhayrab.com for more information about our company and products.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326